Global Opioid Induced Constipation (OIC) Drug Market Insights, Forecast to 2025

Publisher Name :
Date: 15-Jan-2019
No. of pages: 121
Inquire Before Buying

Opioid-induced constipation (OIC) is a common adverse effect experienced by many patients on opioid therapy for chronic pain. OTC medications include stimulant laxatives, stool softeners, and enemas.

The global Opioid Induced Constipation (OIC) Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Opioid Induced Constipation (OIC) Drug market based on company, product type, end user and key regions.

This report studies the global market size of Opioid Induced Constipation (OIC) Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Opioid Induced Constipation (OIC) Drug in these regions.

This research report categorizes the global Opioid Induced Constipation (OIC) Drug market by top players/brands, region, type and end user. This report also studies the global Opioid Induced Constipation (OIC) Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Ironwood Pharmaceuticals

- Daiichi Sankyo Co

- Pfizer

- Progenics Pharmaceuticals

- Shionogi &

- Allergan

- Nektar Therapeutics

- Purdue Pharma

- S.L.A. Pharma

- Mundipharma International Limited

- Ono Pharmaceutical

- Takeda Pharmaceutical Company Limited

- Theravance Biopharma

- Valeant Pharmaceuticals International

- Cosmo Pharmaceuticals SA

- Daewoong Pharmaceutical

- C.B. Fleet Company

- Sucampo Pharmaceuticals

Market size by Product

- Lubiprostone

- Methyl Naltrexone Bromide

- Naldemedine

- Alvimopan

- Other

Market size by End User

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Opioid Induced Constipation (OIC) Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Opioid Induced Constipation (OIC) Drug market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Opioid Induced Constipation (OIC) Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Opioid Induced Constipation (OIC) Drug submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Opioid Induced Constipation (OIC) Drug are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Opioid Induced Constipation (OIC) Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Opioid Induced Constipation (OIC) Drug Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Opioid Induced Constipation (OIC) Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Product
1.4.2 Lubiprostone
1.4.3 Methyl Naltrexone Bromide
1.4.4 Naldemedine
1.4.5 Alvimopan
1.4.6 Other
1.5 Market by End User
1.5.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by End User
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Opioid Induced Constipation (OIC) Drug Market Size
2.1.1 Global Opioid Induced Constipation (OIC) Drug Revenue 2014-2025
2.1.2 Global Opioid Induced Constipation (OIC) Drug Sales 2014-2025
2.2 Opioid Induced Constipation (OIC) Drug Growth Rate by Regions
2.2.1 Global Opioid Induced Constipation (OIC) Drug Sales by Regions
2.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Opioid Induced Constipation (OIC) Drug Sales by Manufacturers
3.1.1 Opioid Induced Constipation (OIC) Drug Sales by Manufacturers
3.1.2 Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers
3.1.3 Global Opioid Induced Constipation (OIC) Drug Market Concentration Ratio (CR5 and HHI)
3.2 Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers
3.2.1 Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2014-2019)
3.2.2 Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2014-2019)
3.3 Opioid Induced Constipation (OIC) Drug Price by Manufacturers
3.4 Opioid Induced Constipation (OIC) Drug Manufacturing Base Distribution, Product Types
3.4.1 Opioid Induced Constipation (OIC) Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Opioid Induced Constipation (OIC) Drug Product Type
3.4.3 Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Opioid Induced Constipation (OIC) Drug Sales by Product
4.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Product
4.3 Opioid Induced Constipation (OIC) Drug Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Opioid Induced Constipation (OIC) Drug Breakdown Data by End User
6 North America
6.1 North America Opioid Induced Constipation (OIC) Drug by Countries
6.1.1 North America Opioid Induced Constipation (OIC) Drug Sales by Countries
6.1.2 North America Opioid Induced Constipation (OIC) Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Opioid Induced Constipation (OIC) Drug by Product
6.3 North America Opioid Induced Constipation (OIC) Drug by End User
7 Europe
7.1 Europe Opioid Induced Constipation (OIC) Drug by Countries
7.1.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Countries
7.1.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Opioid Induced Constipation (OIC) Drug by Product
7.3 Europe Opioid Induced Constipation (OIC) Drug by End User
8 Asia Pacific
8.1 Asia Pacific Opioid Induced Constipation (OIC) Drug by Countries
8.1.1 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Countries
8.1.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Opioid Induced Constipation (OIC) Drug by Product
8.3 Asia Pacific Opioid Induced Constipation (OIC) Drug by End User
9 Central & South America
9.1 Central & South America Opioid Induced Constipation (OIC) Drug by Countries
9.1.1 Central & South America Opioid Induced Constipation (OIC) Drug Sales by Countries
9.1.2 Central & South America Opioid Induced Constipation (OIC) Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Opioid Induced Constipation (OIC) Drug by Product
9.3 Central & South America Opioid Induced Constipation (OIC) Drug by End User
10 Middle East and Africa
10.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug by Countries
10.1.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Countries
10.1.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug by Product
10.3 Middle East and Africa Opioid Induced Constipation (OIC) Drug by End User
11 Company Profiles
11.1 Ironwood Pharmaceuticals
11.1.1 Ironwood Pharmaceuticals Company Details
11.1.2 Company Business Overview
11.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered
11.1.5 Ironwood Pharmaceuticals Recent Development
11.2 Daiichi Sankyo Co
11.2.1 Daiichi Sankyo Co Company Details
11.2.2 Company Business Overview
11.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Products Offered
11.2.5 Daiichi Sankyo Co Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Business Overview
11.3.Pfizer Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Pfizer Opioid Induced Constipation (OIC) Drug Products Offered
11.3.5 Pfizer Recent Development
11.4 Progenics Pharmaceuticals
11.4.1 Progenics Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered
11.4.5 Progenics Pharmaceuticals Recent Development
11.5 Shionogi &
11.5.1 Shionogi & Company Details
11.5.2 Company Business Overview
11.5.3 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Shionogi & Opioid Induced Constipation (OIC) Drug Products Offered
11.5.5 Shionogi & Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Company Business Overview
11.6.3 Allergan Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Allergan Opioid Induced Constipation (OIC) Drug Products Offered
11.6.5 Allergan Recent Development
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Company Details
11.7.2 Company Business Overview
11.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Products Offered
11.7.5 Nektar Therapeutics Recent Development
11.8 Purdue Pharma
11.8.1 Purdue Pharma Company Details
11.8.2 Company Business Overview
11.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drug Products Offered
11.8.5 Purdue Pharma Recent Development
11.9 S.L.A. Pharma
11.9.1 S.L.A. Pharma Company Details
11.9.2 Company Business Overview
11.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.9.4 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Products Offered
11.9.5 S.L.A. Pharma Recent Development
11.10 Mundipharma International Limited
11.10.1 Mundipharma International Limited Company Details
11.10.2 Company Business Overview
11.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Products Offered
11.10.5 Mundipharma International Limited Recent Development
11.11 Ono Pharmaceutical
11.12 Takeda Pharmaceutical Company Limited
11.13 Theravance Biopharma
11.14 Valeant Pharmaceuticals International
11.15 Cosmo Pharmaceuticals SA
11.16 Daewoong Pharmaceutical
11.17 C.B. Fleet Company
11.18 Sucampo Pharmaceuticals
12 Future Forecast
12.1 Opioid Induced Constipation (OIC) Drug Market Forecast by Regions
12.1.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Regions 2019-2025
12.2 Opioid Induced Constipation (OIC) Drug Market Forecast by Product
12.2.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Product 2019-2025
12.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Product 2019-2025
12.3 Opioid Induced Constipation (OIC) Drug Market Forecast by End User
12.4 North America Opioid Induced Constipation (OIC) Drug Forecast
12.5 Europe Opioid Induced Constipation (OIC) Drug Forecast
12.6 Asia Pacific Opioid Induced Constipation (OIC) Drug Forecast
12.7 Central & South America Opioid Induced Constipation (OIC) Drug Forecast
12.8 Middle East and Africa Opioid Induced Constipation (OIC) Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Opioid Induced Constipation (OIC) Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Opioid Induced Constipation (OIC) Drug Product Picture
Table Opioid Induced Constipation (OIC) Drug Market Segments
Table Key Manufacturers Opioid Induced Constipation (OIC) Drug Covered
Table Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Product 2014-2025
Figure Lubiprostone Product Picture
Table Major Manufacturers of Lubiprostone
Figure Methyl Naltrexone Bromide Product Picture
Table Major Manufacturers of Methyl Naltrexone Bromide
Figure Naldemedine Product Picture
Table Major Manufacturers of Naldemedine
Figure Alvimopan Product Picture
Table Major Manufacturers of Alvimopan
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Online Pharmacies
Figure Opioid Induced Constipation (OIC) Drug Report Years Considered
Figure Global Opioid Induced Constipation (OIC) Drug Market Size 2014-2025 (Million US$)
Figure Global Opioid Induced Constipation (OIC) Drug Sales 2014-2025 (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Sales by Regions 2014-2019 (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions 2014-2019
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions 2014-2019
Figure 2018 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions
Table Global Opioid Induced Constipation (OIC) Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions 2014-2019
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions 2014-2019
Figure 2018 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions
Table Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturers (2014-2019) (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers (2014-2019)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2014-2019)
Figure Opioid Induced Constipation (OIC) Drug Value Share by Manufacturers in 2018
Table Key Manufacturers Opioid Induced Constipation (OIC) Drug Price (2014-2019) (USD/Unit)
Table Opioid Induced Constipation (OIC) Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Opioid Induced Constipation (OIC) Drug Product Type
Table Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Opioid Induced Constipation (OIC) Drug Sales by Product (2014-2019) (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Share by Product (2014-2019)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Product (2014-2019)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Product in 2018
Table Global Opioid Induced Constipation (OIC) Drug Revenue by Product (2014-2019) (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Revenue Share by Product (2014-2019)
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Product (2014-2019)
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Product in 2018
Table Opioid Induced Constipation (OIC) Drug Price by Product 2014-2019 (USD/Unit)
Table Global Opioid Induced Constipation (OIC) Drug Sales by End User (2014-2019) (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Share by End User (2014-2019)
Figure Global Sales Opioid Induced Constipation (OIC) Drug Market Share by End User (2014-2019)
Figure Global Sales Opioid Induced Constipation (OIC) Drug Market Share by End User in 2018
Figure North America Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2014-2019 (K Units)
Figure North America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2014-2019 (Million US$)
Table North America Opioid Induced Constipation (OIC) Drug Sales by Countries (2014-2019) (K Units)
Table North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2014-2019)
Figure 2018 North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table North America Opioid Induced Constipation (OIC) Drug Revenue by Countries (2014-2019) (Million US$)
Table North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure United States Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure United States Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Canada Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Table North America Opioid Induced Constipation (OIC) Drug Sales by Product (2014-2019) (K Units)
Table North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Product (2014-2019)
Figure 2018 North America Opioid Induced Constipation (OIC) Drug Market Share by Product
Table North America Opioid Induced Constipation (OIC) Drug Sales by End User (2014-2019) (K Units)
Table North America Opioid Induced Constipation (OIC) Drug Sales Market Share by End User (2014-2019)
Figure 2018 North America Opioid Induced Constipation (OIC) Drug Market Share by End User
Figure Europe Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2014-2019 (K Units)
Figure Europe Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Opioid Induced Constipation (OIC) Drug Sales by Countries (2014-2019) (K Units)
Table Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table Europe Opioid Induced Constipation (OIC) Drug Revenue by Countries (2014-2019) (Million US$)
Table Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure Germany Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Germany Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure France Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure France Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure UK Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Italy Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Russia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Opioid Induced Constipation (OIC) Drug Sales by Product (2014-2019) (K Units)
Table Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Product (2014-2019)
Figure 2018 Europe Opioid Induced Constipation (OIC) Drug Market Share by Product
Table Europe Opioid Induced Constipation (OIC) Drug Sales by End User (2014-2019) (K Units)
Table Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by End User (2014-2019)
Figure 2018 Europe Opioid Induced Constipation (OIC) Drug Market Share by End User
Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure China Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure China Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Japan Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Korea Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure India Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure India Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Australia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Product (2014-2019) (K Units)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Share by Product
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by End User (2014-2019) (K Units)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Share by End User
Figure Central & South America Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales by Countries (2014-2019) (K Units)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table Central & South America Opioid Induced Constipation (OIC) Drug Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure Brazil Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales by Product (2014-2019) (K Units)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Opioid Induced Constipation (OIC) Drug Market Share by Product
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales by End User (2014-2019) (K Units)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Opioid Induced Constipation (OIC) Drug Market Share by End User
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure GCC Countries Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Share by Product
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Share by End User
Table Ironwood Pharmaceuticals Company Details
Table Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Ironwood Pharmaceuticals Recent Development
Table Daiichi Sankyo Co Company Details
Table Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Daiichi Sankyo Co Recent Development
Table Pfizer Company Details
Table Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Progenics Pharmaceuticals Company Details
Table Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Progenics Pharmaceuticals Recent Development
Table Shionogi & Company Details
Table Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Shionogi & Recent Development
Table Allergan Company Details
Table Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan Recent Development
Table Nektar Therapeutics Company Details
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Nektar Therapeutics Recent Development
Table Purdue Pharma Company Details
Table Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Purdue Pharma Recent Development
Table S.L.A. Pharma Company Details
Table S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table S.L.A. Pharma Recent Development
Table Mundipharma International Limited Company Details
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mundipharma International Limited Recent Development
Table Ono Pharmaceutical Company Details
Table Takeda Pharmaceutical Company Limited Company Details
Table Theravance Biopharma Company Details
Table Valeant Pharmaceuticals International Company Details
Table Cosmo Pharmaceuticals SA Company Details
Table Daewoong Pharmaceutical Company Details
Table C.B. Fleet Company Company Details
Table Sucampo Pharmaceuticals Company Details
Table Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Regions 2019-2025 (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Regions 2019-2025
Table Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Product 2019-2025 (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Product 2019-2025
Table Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Product 2019-2025
Table Global Opioid Induced Constipation (OIC) Drug Sales Forecast by End User 2019-2025 (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by End User 2019-2025
Figure North America Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Opioid Induced Constipation (OIC) Drug Value Chain
Table Opioid Induced Constipation (OIC) Drug Customers List
Table Opioid Induced Constipation (OIC) Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Hyperimmune Globulins Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 159
    Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccine......
  • Global Rydapt Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Rydapt is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis. North America is the largest Sales place, with a Sales market share nearly 75.2% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 24.8%. In USA, The National Cancer Institute estimates that in 2017 approximately 21,380 people will be diagn......
  • Global Cabazitaxel Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 132
    Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy. Global cabazitaxel production regions are mainly distributed in USA and Europe. There is no doubt that USA is the largest production region in the world. In......
  • Global Equine Pharmaceuticals and Supplements Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 158
    Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases. In the last several years, global market of Equine Pharmaceuticals and Supplements developed rapidly, with an average growth rate of 4.52% during 2013 to 2017. In 2017, global revenue of Equine Pharmaceuticals and Supplements is nearly 977 M USD; the actual production is about 13700 K Unit. Market competition is not intense. Boehringer Ingelheim, Me......
  • Global Levonorgestrel Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 130
    Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantab......
  • Global HPQ & Silica for Pharmaceutical Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Jan-2019        Price: US 3480 Onwards        Pages: 116
    Scope of the Report: The worldwide market for HPQ & Silica for Pharmaceutical is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the HPQ & Silica for Pharmaceutical in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based o......
  • Global Non-animal Softgel Capsules Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Jan-2019        Price: US 3480 Onwards        Pages: 121
    Scope of the Report: The worldwide market for Non-animal Softgel Capsules is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Non-animal Softgel Capsules in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufa......
  • Global Oil Softgel Capsules Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Jan-2019        Price: US 3480 Onwards        Pages: 123
    Scope of the Report: The worldwide market for Oil Softgel Capsules is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Oil Softgel Capsules in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regio......
  • Global Betamethasone-21-Acetate Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Jan-2019        Price: US 3480 Onwards        Pages: 138
    Scope of the Report: The worldwide market for Betamethasone-21-Acetate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Betamethasone-21-Acetate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturer......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs